Discovery Life Sciences to Acquire Gentest Business from Corning Incorporated

BIOSPECIMEN LEADER TO COMBINE GENTEST WITH RECENT IVAL ACQUISITION TO CREATE LEADING IN VITRO DRUG METABOLISM SERVICES OFFERING HUNTSVILLE, Ala., April 5, 2022 /PRNewswire/ — Discovery Life Sciences™ (Discovery), the biospecimen and biomarker specialists™, announced today that it has…

About the Author

has written 41292 stories on this site.

Copyright © 2010 Business and Corporate News.